TNBC is a special subtype of breast cancer that lacks oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor type 2 (HER2) gene expression, all of which are molecular targets of therapeutic agents1. The gene discussed is PGR; the disease is breast carcinoma.